Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies

Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):e495-e497. doi: 10.1016/j.clml.2022.01.010. Epub 2022 Jan 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19* / prevention & control
  • Hematologic Neoplasms* / therapy
  • Humans
  • Immunization
  • Seroconversion
  • Vaccination